In addition to not being a non-randomized controlled trial, criticisms of the study include that the published data was not sufficient to establish a causal association between GLP-1 receptor agonist use and NAION
It is just disturbing that the federal government, the largest payer of healthcare in the United States, does not have audit rights to go in, open up the ledgers of the pharmacy benefit managers, see where the money is going, whether or not all the concessions have been transferred to the federal government or not in the form of rebates, fees, discounts, any and all, every single penny, and then to have more updated information because as you know, Conner, healthcare is very dynamic, especially in the pharmaceutical space
Prescribed as either a generic or under the brand name Contrave, which is a single pill FDA approved in 2014, its a combination of two medications: bupropion and naltrexone
Managing stress is not a luxury during treatment
But here is what that headline does not tell you